MD, FACOG, FACS, has served as a faculty member on the Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, since 1997. He is currently the Deputy Chief of the Gynecology Service and head of the Ovarian Cancer Surgery Section. He was co-director of Pelvic Reconstructive surgery, Director of the Gynecologic Oncology Fellowship and the Pelvic Reconstruction Clinical Research Fellowships from 2001-2014. He helped to establish the International Gynecologic Oncology Fellowship program at MSKCC.
His experience in population-based and patient-oriented research have led to over 200 peer-reviewed publications and international presentations that have demonstrated the safe use of advanced minimally invasive surgical techniques in the management of early ovarian cancer, the beneficial effects of the use of extensive surgical procedures for advanced and recurrent gynecologic cancers, and the establishment of clinical guidelines to determine appropriate candidates for second and third operations in cases of recurrent uterine and ovarian cancer.
Dr. Chi is the principal investigator of four current MSKCC IRB-approved prospective clinical protocols including a randomized, multicenter phase II trial comparing secondary cytoreductive surgery with and without Hearted Intraperitoneal Chemotherapy in patients with recurrent ovarian cancer. On a national level, he has served multiple times as the director or faculty member of the Society of Gynecologic Oncology’s annual postgraduate courses aimed at instructing gynecologic oncologists throughout the world on the most up-to-date surgical treatments for women with gynecologic malignancies.